A dose-dependent decrease in the fraction of cases harboring M6P/IGF2R mutations in hepatocellular carcinomas from the atomic bomb survivors

Radiation Research

Volumn 166, Issue 6, 2006, Pages 870-876

  Iwamoto, Keisuke S ^a,b   Yano, Shiho ^a   Barber, Chad L ^b   MacPhee, Donald G ^a   Tokuoka, Shoji ^a  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LUCIFERASE; MESSENGER RNA;

ARTICLE; ATOMIC BOMB; ATOMIC BOMB SURVIVOR; CANCER RISK; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE;

BODY BURDEN; CARCINOMA, HEPATOCELLULAR; DNA MUTATIONAL ANALYSIS; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; JAPAN; LIVER NEOPLASMS; MALE; MANNOSEPHOSPHATES; MUTATION; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; RADIATION DOSAGE; RECEPTOR, IGF TYPE 2; RISK ASSESSMENT; RISK FACTORS; SURVIVORS;

EID: 33845357230     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR0585.1     Document Type: Article

References (38)

1. M. C. Yu, J. M. Yuan, S. Govindarajan and R. K. Ross, Epidemiology of hepatocellular carcinoma. Can. J. Gastroenterol. 14, 703-709 (2000).
2. J. B. Cologne, S. Tokuoka, G. W. Beebe, T. Fukuhara and K. Mabuchi, Effects of radiation on incidence of primary liver cancer among atomic bomb survivors. Radiat. Res. 152, 364-373 (1999).
3. D. E. Thompson, K. Mabuchi, E. Ron, M. Soda, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda, M. Terasaki and D. Preston, Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat. Res. 137 (Suppl.), S17-S67 (1994).
4. K. S. Iwamoto, T. Mizuno, S. Tokuoka, K. Mabuchi and T. Seyama, Frequency of p53 mutations in hepatocellular carcinomas from atomic bomb survivors. J. Natl. Cancer Inst. 90, 1167-1168 (1998).
5. A. T. De Souza, G. R. Hankins, M. K. Washington, T. C. Orton and R. L. Jirtle, M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat. Genet. 11, 447-449 (1995).
6. T. Yamada, A. T. De Souza, S. Finkelstein and R. L. Jirtle, Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc. Natl. Acad. Sci. USA 94, 10351-10355 (1997).
7. M. J. Ellis, B. A. Leav, Z. Yang, A. Rasmussen, A. Pearce, J. A. Zweibel, M. E. Lippman and K. J. Cullen, Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol. Endocrinol. 10, 286-297 (1996).
8. N. M. Dahms, P. Lobel and S. Kornfield, Mannose 6-phosphate receptors and lysosomal enzyme targeting. J. Biol. Chem. 264, 12115-12118 (1989).
9. M. R. Buck, D. G. Karustis, N. A. Day, K. V. Honn and B. F. Sloane, Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem. J. 282, 273-278 (1992).
10. B. Friedrich, K. Jung, M. Lein, I. Turk, B. Rudolph, G. Hampel, D. Schnorr and S. A. Loening, Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue. Eur. J. Cancer 35, 138-144 (1999).
11. J. A. Barnard, R. M. Lyons and H. L. Moses, The cell biology of transforming growth factor-β. Biochim. Biophys. Acta 1032, 79-87 (1990).
12. J. Wang, K. K. Richter, C. C. Sung and M. Hauer-Jensen, Upregulation and spatial shift in the localization of the mannose 6-phosphate/insulin-like growth factor II receptor during radiation enteropathy development in the rat. Radiother. Oncol. 50, 205-213 (1999).
13. R. F. Souza, S. Wang, M. Thakar, S. N. Smolinski, J. Yin, T. T. Zou, D. Kong, J. M. Abraham, J. A. Toretsky and S. J. Meltzer, Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells. Oncogene 18, 4063-4068 (1999).
14. D. B. O'Gorman, M. Costello, J. Weiss, S. M. Firth and C. D. Scott, Decreased insulin-like growth factor-II/mannose 6-phosphate receptor expression enhances tumorigenicity in JEG-3 cells. Cancer Res. 59, 5692-5694 (1999).
15. K. S. Iwamoto, T. Mizuno, T. Ito, M. Akiyama, N. Takeichi, K. Mabuchi and T. Seyama, Feasibility of using decades-old archival tissues in molecular oncology/epidemiology. Am. J. Pathol. 149, 399-406 (1996).
16. J. Goto, D. A. Figlewicz, C. Marineau, N. Khodr and G. A. Rouleau, Dinucleotide repeat polymorphism at the IGF2R locus. Nucleic Acids Res. 20, 923 (1992).
17. J. K. Killian, Y. Oka, H. S. Jang, X. Fu, R. A. Waterland, T. Sohda, S. Sakaguchi and R. L. Jirtle, Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations. Hum. Mutat. 18, 25-31 (2001).
18. I. Wada, H. Kanada, K. Nomura, Y. Kato, R. Machinami and T. Kitagawa, Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan. Hepatology 29, 1718-1721 (1999).
19. D. Liu, H. Momoi, L. Li, Y. Ishikawa and M. Fukumoto, Microsatellite instability in Thorotrast-induced human intrahepatic cholangiocarcinoma. Int. J. Cancer 102, 366-371 (2002).
20. S. Markowitz, J. Wang, L. Myeroff, R. Parsons, L. Sun, J. Lutterbaugh, R. S. Fan, E. Zborowska, K. W. Kinzler and J. K. V. Willson, Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338 (1995).
21. L. L. Myeroff, R. Parsons, S. J. Kim, L. Hedrick, K. R. Cho, K. Orth, M. Mathis, K. W. Kinzler, J. Lutterbaugh and K. Park, A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res. 55, 5545-5547 (1995).
22. R. F. Souza, R. Appel, J. Yin, S. Wang, K. N. Smolinski, J. M. Abraham, T. T. Zou, Y. Q. Shi, J. Lei and S. J. Meltzer, Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat. Genet. 14, 255-257 (1996).
23. S. Xie and J. X. Kang, Differential expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential. Med. Sci. Monit. 8, BR293-BR300 (2000).
24. T. Misteli and D. L. Spector, The cellular organization of gene expression. Curr. Opin. Cell. Biol. 10, 323-331 (1998).
25. J. L. Hargrove, M. G. Hulsey and E. G. Beale, The kinetics of mammalian gene expression. Bioessays 13, 667-674 (1991).
26. A. Spicher, O. M. Guicherit, L. Duret, A. Aslanian, E. M. Sanjines, N. C. Denko, A. J. Giaccia and H. M. Blau, Highly conserved RNA sequences that are sensors of environmental stress. Mol. Cell Biol. 18, 7371-7382 (1998).
27. T. Henics, E. Nagy, H. J. Oh, P. Csermely, A. von Gabain and J. R. Subjeck, Mammalian Hsp70 and Hsp110 proteins bind to RNA motifs involved in mRNA stability. J. Biol. Chem. 274, 17318-17324 (1999).
28. A. Jenny, H. J. Hauri and W. Keller, Characterization of cleavage and polyadenylation specificity factor and cloning of its 100-kilodalton subunit. Mol. Cell Biol. 14, 8183-8190 (1994).
29. W. Keller, S. Bienroth, K. M. Lang and G. Christofori, Cleavage and polyadenylation factor CPF specifically interacts with the pre-mRNA 3 processing signal AAUAAA. EMBO J. 10, 4241-4249 (1991).
30. Y. Takagaki, J. L. Manley, C. C. MacDonald, J. Wilusz and T. Shenk, A multisubunit factor, CstF, is required for polyadenylation of mammalian pre-mRNAs. Genes Dev. 4, 2112-2120 (1990).
31. Y. Takagaki and J. L. Manley, RNA recognition by the human polyadenylation factor CstF. Mol. Cell Biol. 17, 3907-3914 (1997).
32. T. Schutz, A. Kairat and C. H. Schroder, DNA sequence requirements for the activation of a CATAAA polyadenylation signal within the hepatitis B virus X reading frame: Rapid detection of truncated transcripts. Virology 223, 401-405 (1996).
33. F. E. Kleiman and J. L. Manley, Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF. Science 285, 1576-1579 (1999).
34. M. D. Koffa, S. V. Graham, Y. Takagaki, J. L. Manley and J. B. Clements, The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different post-transcriptional levels. Proc. Natl. Acad. Sci. USA 97, 4677-4682 (2000).
35. G. B. Sharp, T. Mizuno, J. B. Cologne, T. Fukuhara, S. Fujiwara, S. Tokuoka and K. Mabuchi, Hepatocellular carcinoma among atomic bomb survivors: Significant interaction of radiation with hepatitis C virus infections. Int. J. Cancer 103, 531-537 (2003).
36. H. Kawai, T. Suda, Y. Aoyagi, O. Isokawa, Y. Mita, N. Waguri, T. Kuroiwa, M. Igarashi, K. Tsukada and H. Asakura, Quantitative evaluation of genomic instability as a possible predictor for development of hepatocellular carcinoma: comparison of loss of heterozygosity and replication error. Hepatology 31, 1246-1250 (2000).
37. H. Yamamoto, F. Itoh, H. Fukushima, H. Kaneto, S. Sasaki, T. Ohmura, T. Satoh, Y. Karino, T. Endo and K. Imai, Infrequent widespread microsatellite instability in hepatocellular carcinomas. Int. J. Oncol. 16, 543-547 (2000).
38. Y. Oka, R. A. Waterland, J. K. Killian, C. M. Nolan, H. S. Jang, K. Tohara, S. Sakaguchi, T. Yao, A. Iwashita and R. L. Jirtle, M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan. Hepatology 35, 1153-1163 (2002).